| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
85,860 |
76,359 |
$26.61M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
390,685 |
307,935 |
$25.35M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
94,932 |
86,878 |
$23.33M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,908 |
20,352 |
$13.37M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
33,163 |
31,433 |
$13.06M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
169,835 |
157,466 |
$8.02M |
| T1015 |
Clinic visit/encounter, all-inclusive |
17,546 |
13,619 |
$7.43M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
192,763 |
178,556 |
$6.89M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
27,396 |
10,746 |
$5.25M |
| 47562 |
|
1,262 |
1,235 |
$4.62M |
| J9271 |
Injection, pembrolizumab, 1 mg |
501 |
382 |
$4.28M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,529 |
21,518 |
$4.18M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13,014 |
12,288 |
$4.13M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
41,404 |
40,358 |
$3.68M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
877 |
862 |
$3.33M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13,369 |
12,762 |
$3.21M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
4,948 |
4,750 |
$3.05M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
45,025 |
26,712 |
$2.82M |
| 27447 |
|
866 |
779 |
$2.61M |
| 47563 |
|
527 |
496 |
$2.54M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
20,545 |
19,979 |
$2.39M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
6,242 |
5,993 |
$2.18M |
| 93458 |
|
1,379 |
1,291 |
$2.15M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
9,707 |
8,958 |
$1.90M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
30,772 |
29,449 |
$1.86M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
59,173 |
56,366 |
$1.84M |
| 70450 |
Computed tomography, head or brain; without contrast material |
33,227 |
30,785 |
$1.70M |
| 58661 |
|
317 |
310 |
$1.69M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
3,189 |
3,069 |
$1.67M |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,676 |
1,641 |
$1.65M |
| 76641 |
|
16,008 |
15,617 |
$1.64M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
5,369 |
4,874 |
$1.46M |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
1,125 |
976 |
$1.44M |
| 20611 |
|
10,855 |
7,915 |
$1.43M |
| 49083 |
|
5,901 |
2,983 |
$1.41M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
63,062 |
46,600 |
$1.41M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
43,789 |
40,742 |
$1.36M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
34,593 |
15,501 |
$1.36M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28,093 |
27,159 |
$1.35M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
9,550 |
8,767 |
$1.31M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15,295 |
14,581 |
$1.30M |
| 19083 |
|
1,066 |
973 |
$1.24M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
10,333 |
7,514 |
$1.24M |
| 99233 |
Prolong inpt eval add15 m |
21,495 |
9,608 |
$1.22M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17,034 |
16,492 |
$1.20M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
16,584 |
16,168 |
$1.17M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
29,936 |
27,534 |
$1.14M |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
11,236 |
10,464 |
$1.14M |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
5,145 |
3,366 |
$1.13M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14,395 |
13,523 |
$1.12M |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
2,254 |
2,232 |
$1.10M |
| 92587 |
|
5,609 |
5,308 |
$1.10M |
| 11045 |
|
3,448 |
1,340 |
$1.08M |
| 59025 |
Fetal non-stress test |
30,604 |
17,639 |
$1.03M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13,110 |
12,465 |
$1.02M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,021 |
4,829 |
$1.02M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
8,882 |
7,643 |
$976K |
| 84439 |
|
26,838 |
25,765 |
$954K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
92,270 |
67,795 |
$921K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,451 |
5,154 |
$870K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
262 |
105 |
$840K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14,407 |
14,076 |
$822K |
| G0378 |
Hospital observation service, per hour |
68,728 |
29,070 |
$815K |
| 20610 |
|
5,421 |
4,137 |
$811K |
| 71046 |
Radiologic examination, chest; 2 views |
54,770 |
51,599 |
$810K |
| 80053 |
Comprehensive metabolic panel |
212,299 |
170,040 |
$782K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
12,905 |
12,424 |
$759K |
| 58558 |
|
394 |
382 |
$740K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
9,892 |
8,856 |
$721K |
| 99215 |
Prolong outpt/office vis |
11,164 |
9,579 |
$689K |
| 99460 |
|
9,701 |
9,560 |
$680K |
| 36902 |
|
944 |
854 |
$678K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,672 |
10,533 |
$672K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,410 |
1,348 |
$656K |
| 77080 |
|
12,635 |
12,098 |
$654K |
| 99222 |
Initial hospital care, per day, moderate complexity |
8,707 |
8,388 |
$650K |
| C1776 |
Joint device (implantable) |
697 |
650 |
$649K |
| 76536 |
|
9,203 |
8,987 |
$606K |
| 74178 |
|
2,019 |
1,899 |
$593K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
415 |
408 |
$590K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
82,821 |
70,589 |
$583K |
| 70496 |
|
2,065 |
1,974 |
$578K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,135 |
4,704 |
$570K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,447 |
932 |
$566K |
| 86900 |
|
18,197 |
16,482 |
$563K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
9,136 |
9,002 |
$556K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25,510 |
24,717 |
$535K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
15,248 |
14,771 |
$516K |
| 73110 |
|
8,265 |
6,869 |
$500K |
| 76770 |
|
9,218 |
8,906 |
$497K |
| 73630 |
|
12,115 |
11,058 |
$493K |
| 72110 |
|
5,942 |
5,829 |
$490K |
| J0897 |
Injection, denosumab, 1 mg |
1,010 |
922 |
$489K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
3,739 |
3,456 |
$488K |
| 88342 |
|
17,229 |
16,021 |
$477K |
| 88307 |
|
7,853 |
7,493 |
$476K |
| 73610 |
|
8,987 |
8,187 |
$458K |
| 29848 |
|
505 |
492 |
$449K |
| 77334 |
|
442 |
401 |
$442K |
| 73130 |
|
7,803 |
6,889 |
$440K |
| 73030 |
|
13,723 |
12,292 |
$438K |
| 43248 |
|
835 |
808 |
$436K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,624 |
2,434 |
$422K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
17,088 |
16,553 |
$422K |
| 74183 |
|
1,702 |
1,636 |
$421K |
| 00731 |
|
2,963 |
2,905 |
$417K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,956 |
4,833 |
$414K |
| 83970 |
|
5,298 |
4,979 |
$411K |
| 84403 |
|
3,783 |
3,624 |
$407K |
| 77066 |
Tomosynthesis, mammo |
5,991 |
5,873 |
$401K |
| 99201 |
|
18,637 |
17,620 |
$400K |
| 93976 |
|
11,191 |
10,826 |
$389K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,435 |
3,187 |
$387K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
3,912 |
3,670 |
$383K |
| 76801 |
|
4,838 |
4,413 |
$380K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
3,780 |
3,267 |
$361K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
49,297 |
47,096 |
$342K |
| 99223 |
Prolong inpt eval add15 m |
3,477 |
3,323 |
$325K |
| 00811 |
|
2,557 |
2,494 |
$315K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
544 |
500 |
$314K |
| 73560 |
|
7,383 |
6,300 |
$295K |
| 94060 |
|
1,395 |
1,335 |
$288K |
| 90677 |
|
2,216 |
2,152 |
$286K |
| 73221 |
|
2,444 |
2,256 |
$283K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
474 |
288 |
$280K |
| 76830 |
Ultrasound, transvaginal |
17,866 |
17,385 |
$276K |
| 77412 |
|
2,469 |
243 |
$276K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
2,241 |
1,617 |
$272K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,002 |
1,964 |
$264K |
| 93798 |
|
3,120 |
511 |
$261K |
| 73562 |
|
9,451 |
8,468 |
$255K |
| 72100 |
|
5,500 |
5,320 |
$252K |
| 93970 |
|
2,392 |
2,270 |
$246K |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
41 |
38 |
$243K |
| 72131 |
|
1,335 |
1,244 |
$241K |
| 77427 |
|
2,092 |
887 |
$234K |
| 73564 |
|
3,014 |
2,566 |
$233K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
30,075 |
29,399 |
$229K |
| 96415 |
|
2,807 |
1,919 |
$228K |
| 95117 |
|
7,612 |
3,432 |
$226K |
| 44970 |
|
41 |
40 |
$219K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,445 |
3,396 |
$218K |
| 77065 |
Tomosynthesis, mammo |
6,521 |
6,042 |
$217K |
| 36430 |
|
2,659 |
1,913 |
$216K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
45,783 |
39,520 |
$215K |
| 99219 |
|
3,224 |
3,003 |
$212K |
| 31575 |
|
1,900 |
1,818 |
$208K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
6,208 |
5,732 |
$208K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,392 |
2,831 |
$197K |
| 71045 |
Radiologic examination, chest; single view |
56,461 |
50,911 |
$197K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
564 |
310 |
$194K |
| 77385 |
|
708 |
63 |
$192K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
224 |
221 |
$191K |
| 80074 |
|
3,950 |
3,797 |
$190K |
| 86003 |
|
2,470 |
1,245 |
$189K |
| 74018 |
|
7,486 |
7,126 |
$185K |
| 93454 |
|
162 |
145 |
$182K |
| 76818 |
|
3,006 |
2,212 |
$182K |
| 71250 |
|
3,723 |
3,490 |
$178K |
| 72141 |
|
1,121 |
1,054 |
$178K |
| 58301 |
|
571 |
558 |
$177K |
| J7300 |
Intrauterine copper contraceptive (paragard) |
144 |
144 |
$174K |
| 93971 |
|
4,484 |
4,211 |
$172K |
| 73502 |
|
5,784 |
5,097 |
$168K |
| 77014 |
|
7,186 |
922 |
$165K |
| 58670 |
|
38 |
38 |
$165K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,658 |
3,489 |
$162K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
22,198 |
19,950 |
$159K |
| 0450 |
Emergency room services |
3,163 |
2,729 |
$157K |
| 36561 |
|
87 |
84 |
$156K |
| 88341 |
|
4,081 |
3,616 |
$154K |
| 30520 |
|
62 |
62 |
$152K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,635 |
1,283 |
$151K |
| 87625 |
|
1,032 |
789 |
$151K |
| 74174 |
|
484 |
446 |
$149K |
| 76870 |
|
2,894 |
2,778 |
$147K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,063 |
2,020 |
$139K |
| 70486 |
|
2,800 |
2,596 |
$139K |
| 69210 |
|
2,566 |
2,419 |
$139K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,969 |
1,876 |
$138K |
| 99217 |
|
3,716 |
3,478 |
$137K |
| 77012 |
|
184 |
163 |
$129K |
| 91200 |
|
1,987 |
1,960 |
$128K |
| 73140 |
|
2,467 |
2,225 |
$127K |
| 90671 |
|
1,985 |
1,976 |
$125K |
| 31231 |
|
882 |
868 |
$124K |
| 84146 |
|
4,233 |
3,948 |
$123K |
| 73080 |
|
3,035 |
2,702 |
$123K |
| 52000 |
|
900 |
877 |
$122K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
47 |
40 |
$120K |
| 94010 |
|
1,114 |
1,065 |
$120K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
364 |
332 |
$116K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
170 |
167 |
$115K |
| 72197 |
|
496 |
468 |
$114K |
| 73590 |
|
4,156 |
3,753 |
$113K |
| 72050 |
|
2,158 |
2,106 |
$111K |
| 74170 |
|
583 |
545 |
$109K |
| 83690 |
|
51,815 |
45,270 |
$109K |
| 74246 |
|
730 |
723 |
$108K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
206,775 |
158,304 |
$105K |
| 72170 |
|
3,282 |
3,062 |
$103K |
| 90791 |
Psychiatric diagnostic evaluation |
1,028 |
963 |
$99K |
| 76642 |
|
1,295 |
1,275 |
$99K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,332 |
1,321 |
$97K |
| H0031 |
Mental health assessment, by non-physician |
696 |
655 |
$94K |
| 72040 |
|
2,315 |
2,240 |
$94K |
| 77049 |
|
260 |
254 |
$93K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,258 |
14,551 |
$93K |
| 72082 |
|
927 |
913 |
$92K |
| 78306 |
|
451 |
428 |
$91K |
| 95816 |
|
520 |
509 |
$91K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,724 |
8,821 |
$91K |
| 73090 |
|
3,206 |
2,795 |
$88K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16,103 |
15,348 |
$87K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,562 |
1,507 |
$86K |
| 43235 |
|
174 |
166 |
$83K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
42,463 |
31,767 |
$83K |
| 84702 |
|
10,371 |
8,110 |
$81K |
| 83013 |
|
2,209 |
2,173 |
$81K |
| 93880 |
|
1,532 |
1,432 |
$79K |
| 86803 |
|
8,016 |
7,815 |
$78K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
42,117 |
34,401 |
$78K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
202 |
197 |
$78K |
| J3489 |
Injection, zoledronic acid, 1 mg |
1,202 |
1,095 |
$78K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14,289 |
9,008 |
$75K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
9,362 |
9,202 |
$74K |
| 90651 |
|
3,024 |
2,920 |
$73K |
| 70491 |
|
745 |
708 |
$72K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,319 |
1,258 |
$72K |
| 99243 |
|
874 |
856 |
$70K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
7,357 |
7,218 |
$69K |
| 96523 |
|
1,772 |
1,349 |
$68K |
| 74019 |
|
1,600 |
1,531 |
$66K |
| 82607 |
|
10,598 |
10,178 |
$66K |
| 30901 |
|
533 |
508 |
$65K |
| 73620 |
|
1,761 |
1,615 |
$65K |
| 90670 |
|
8,998 |
8,752 |
$61K |
| 99220 |
|
785 |
713 |
$61K |
| 20550 |
|
226 |
219 |
$60K |
| 51729 |
|
97 |
95 |
$59K |
| 99254 |
|
484 |
475 |
$59K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,226 |
5,067 |
$58K |
| 51702 |
|
2,518 |
2,197 |
$57K |
| 88141 |
|
2,497 |
2,381 |
$57K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,271 |
187 |
$56K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
9,252 |
8,551 |
$56K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
36 |
36 |
$56K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
116 |
110 |
$56K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
669 |
234 |
$55K |
| 73552 |
|
2,383 |
2,168 |
$55K |
| C1874 |
Stent, coated/covered, with delivery system |
403 |
350 |
$54K |
| 83880 |
|
24,511 |
21,057 |
$54K |
| 72070 |
|
1,553 |
1,511 |
$54K |
| A4648 |
Tissue marker, implantable, any type, each |
691 |
623 |
$54K |
| 11043 |
|
260 |
134 |
$53K |
| 76820 |
|
4,244 |
3,138 |
$53K |
| 76942 |
|
812 |
764 |
$51K |
| 76882 |
|
738 |
720 |
$50K |
| 88304 |
|
10,025 |
9,655 |
$49K |
| 58100 |
|
211 |
205 |
$49K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
189 |
129 |
$49K |
| 81511 |
|
619 |
614 |
$49K |
| 73000 |
|
643 |
566 |
$48K |
| 84153 |
|
3,543 |
3,359 |
$48K |
| 84443 |
Thyroid stimulating hormone (TSH) |
49,454 |
47,001 |
$48K |
| 82378 |
|
2,213 |
2,030 |
$48K |
| 73700 |
|
580 |
548 |
$48K |
| 99205 |
Prolong outpt/office vis |
537 |
522 |
$47K |
| 92134 |
|
2,523 |
2,336 |
$47K |
| 73521 |
|
1,580 |
1,521 |
$46K |
| 73060 |
|
1,853 |
1,612 |
$46K |
| 95115 |
|
1,481 |
705 |
$46K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
64 |
60 |
$45K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
628 |
395 |
$45K |
| 20606 |
|
161 |
148 |
$45K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,080 |
3,972 |
$45K |
| 10060 |
|
856 |
814 |
$44K |
| 82533 |
|
1,704 |
1,358 |
$41K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
56,372 |
50,842 |
$40K |
| 76813 |
|
1,242 |
1,204 |
$40K |
| 76821 |
|
2,857 |
2,016 |
$39K |
| 99462 |
|
1,237 |
1,173 |
$38K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,701 |
781 |
$38K |
| 73565 |
|
1,515 |
1,483 |
$38K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
948 |
859 |
$38K |
| 80069 |
|
7,234 |
6,127 |
$37K |
| 82728 |
|
11,121 |
10,492 |
$37K |
| 92504 |
|
9,473 |
8,539 |
$36K |
| 88185 |
|
183 |
173 |
$35K |
| 51798 |
|
2,168 |
1,939 |
$35K |
| 87507 |
|
255 |
252 |
$35K |
| 81001 |
|
105,533 |
92,892 |
$34K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
158 |
138 |
$33K |
| 80061 |
Lipid panel |
44,823 |
42,887 |
$33K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
404 |
402 |
$32K |
| 86480 |
|
777 |
749 |
$31K |
| 73070 |
|
964 |
888 |
$31K |
| 00813 |
|
234 |
232 |
$30K |
| 74022 |
|
7,140 |
6,509 |
$30K |
| 96411 |
|
683 |
457 |
$30K |
| 99255 |
|
178 |
175 |
$29K |
| 95819 |
|
168 |
165 |
$29K |
| 73100 |
|
605 |
571 |
$29K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,124 |
1,567 |
$29K |
| 71270 |
|
309 |
296 |
$29K |
| 76881 |
|
358 |
348 |
$29K |
| 43775 |
|
36 |
30 |
$28K |
| J1453 |
Injection, fosaprepitant, 1 mg |
831 |
576 |
$28K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13,553 |
13,329 |
$27K |
| 74230 |
|
254 |
247 |
$27K |
| 82950 |
|
3,665 |
3,632 |
$26K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
3,495 |
1,429 |
$26K |
| J0490 |
Injection, belimumab, 10 mg |
29 |
12 |
$26K |
| 99381 |
|
417 |
411 |
$26K |
| 11982 |
|
75 |
72 |
$24K |
| 70498 |
|
1,985 |
1,901 |
$24K |
| 87046 |
|
2,818 |
1,327 |
$24K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
43,629 |
38,967 |
$24K |
| 78227 |
|
62 |
62 |
$24K |
| 90837 |
Psychotherapy, 53 minutes with patient |
311 |
202 |
$23K |
| 87340 |
|
7,342 |
7,060 |
$23K |
| G0268 |
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing |
2,857 |
2,630 |
$23K |
| 93925 |
|
259 |
252 |
$22K |
| 87186 |
|
16,604 |
14,044 |
$22K |
| 92557 |
|
5,024 |
4,732 |
$22K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,472 |
908 |
$22K |
| 86800 |
|
1,611 |
1,532 |
$22K |
| 74241 |
|
111 |
109 |
$21K |
| 85027 |
|
55,010 |
46,791 |
$21K |
| 43244 |
|
25 |
25 |
$21K |
| 25600 |
|
139 |
135 |
$20K |
| 74220 |
|
183 |
173 |
$20K |
| 84480 |
|
3,871 |
3,736 |
$20K |
| 72158 |
|
98 |
93 |
$20K |
| 84484 |
|
76,988 |
51,649 |
$20K |
| 87522 |
Neg quan hep c or qual rna |
966 |
845 |
$20K |
| 96417 |
|
2,213 |
1,423 |
$19K |
| 82951 |
|
989 |
967 |
$19K |
| 99225 |
|
678 |
447 |
$19K |
| 87490 |
|
6,460 |
6,244 |
$19K |
| 88112 |
|
2,091 |
1,923 |
$19K |
| 97161 |
|
4,494 |
4,043 |
$19K |
| 20600 |
|
112 |
99 |
$19K |
| 29075 |
|
365 |
342 |
$19K |
| 19081 |
|
12 |
12 |
$19K |
| 20605 |
|
83 |
78 |
$18K |
| 83520 |
|
3,266 |
2,494 |
$18K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
74 |
68 |
$18K |
| 29125 |
|
1,290 |
1,181 |
$18K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,362 |
1,345 |
$18K |
| 64483 |
|
26 |
25 |
$17K |
| 83735 |
|
67,247 |
51,695 |
$17K |
| 96367 |
|
7,702 |
4,454 |
$17K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
30 |
24 |
$17K |
| 85730 |
|
34,290 |
29,610 |
$17K |
| 76000 |
|
2,705 |
2,577 |
$17K |
| 11750 |
|
44 |
44 |
$17K |
| 73660 |
|
495 |
479 |
$17K |
| 73600 |
|
526 |
484 |
$17K |
| 92015 |
Determination of refractive state |
818 |
794 |
$16K |
| 0077U |
|
702 |
655 |
$16K |
| 70544 |
|
863 |
779 |
$16K |
| 99499 |
|
246 |
210 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,640 |
2,589 |
$15K |
| 88361 |
|
123 |
106 |
$15K |
| 99152 |
|
10,157 |
9,067 |
$15K |
| 76377 |
|
213 |
209 |
$15K |
| 75574 |
|
143 |
133 |
$14K |
| 90619 |
|
639 |
616 |
$14K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
525 |
515 |
$14K |
| 62323 |
|
119 |
110 |
$14K |
| 87081 |
|
6,910 |
6,743 |
$14K |
| 83655 |
|
1,955 |
1,925 |
$14K |
| 77074 |
|
117 |
115 |
$14K |
| 80320 |
|
13,071 |
11,445 |
$13K |
| 12001 |
|
1,529 |
1,486 |
$13K |
| J1815 |
Injection, insulin, per 5 units |
10,490 |
7,499 |
$13K |
| 86920 |
|
1,662 |
828 |
$13K |
| 97597 |
|
680 |
347 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,088 |
4,975 |
$12K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
13 |
13 |
$12K |
| 71271 |
|
383 |
354 |
$12K |
| 84520 |
|
3,785 |
3,236 |
$12K |
| 99253 |
|
142 |
140 |
$12K |
| 84305 |
|
314 |
307 |
$12K |
| 77338 |
|
67 |
66 |
$12K |
| 95911 |
|
37 |
35 |
$12K |
| 77300 |
|
922 |
891 |
$12K |
| 71101 |
|
816 |
780 |
$11K |
| 36821 |
|
13 |
13 |
$11K |
| 97605 |
|
364 |
126 |
$11K |
| 99218 |
|
212 |
206 |
$11K |
| 00790 |
|
27 |
25 |
$11K |
| 86850 |
|
18,014 |
16,361 |
$10K |
| 38505 |
|
13 |
12 |
$10K |
| 99221 |
|
193 |
189 |
$10K |
| 84030 |
|
1,340 |
1,293 |
$10K |
| 11044 |
|
26 |
14 |
$10K |
| 99350 |
Prolong home eval add 15m |
188 |
167 |
$10K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,758 |
2,523 |
$10K |
| 99497 |
|
475 |
392 |
$10K |
| 77001 |
|
1,298 |
1,146 |
$10K |
| 80076 |
|
4,239 |
4,008 |
$10K |
| 86334 |
|
322 |
266 |
$10K |
| C1769 |
Guide wire |
10,673 |
7,712 |
$10K |
| 86341 |
|
117 |
83 |
$10K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
331 |
247 |
$10K |
| 87481 |
|
9,425 |
4,758 |
$10K |
| 57454 |
|
477 |
473 |
$9K |
| 36589 |
|
29 |
25 |
$9K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
17 |
13 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
88,960 |
57,388 |
$9K |
| 58300 |
|
1,053 |
1,032 |
$9K |
| 81025 |
|
29,319 |
27,380 |
$9K |
| 92083 |
|
161 |
153 |
$9K |
| J9171 |
Injection, docetaxel, 1 mg |
47 |
26 |
$9K |
| 84445 |
|
1,200 |
1,187 |
$9K |
| 87653 |
|
2,788 |
2,746 |
$9K |
| 85652 |
|
13,909 |
12,996 |
$9K |
| 99442 |
|
384 |
358 |
$9K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
17 |
17 |
$8K |
| 01961 |
|
25 |
25 |
$8K |
| 77301 |
|
13 |
13 |
$8K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
33 |
32 |
$8K |
| 93295 |
|
347 |
329 |
$8K |
| 82274 |
|
2,012 |
1,522 |
$8K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
161 |
158 |
$8K |
| 97116 |
|
4,449 |
3,303 |
$8K |
| 85610 |
|
60,650 |
48,045 |
$8K |
| 99226 |
|
176 |
125 |
$8K |
| 82670 |
|
2,028 |
1,991 |
$8K |
| 81003 |
|
64,974 |
44,880 |
$8K |
| 19000 |
|
26 |
25 |
$8K |
| 99235 |
|
93 |
92 |
$8K |
| 88313 |
|
1,576 |
1,491 |
$8K |
| 77263 |
|
67 |
67 |
$7K |
| 83516 |
|
2,300 |
1,688 |
$7K |
| 99463 |
|
95 |
90 |
$7K |
| 88311 |
|
1,895 |
1,740 |
$7K |
| 97803 |
|
134 |
128 |
$7K |
| 90732 |
|
1,128 |
1,069 |
$7K |
| 70360 |
|
249 |
239 |
$7K |
| 86703 |
|
6,375 |
6,181 |
$7K |
| 86255 |
|
1,148 |
1,069 |
$7K |
| 85379 |
|
5,173 |
4,779 |
$7K |
| 82962 |
|
107,436 |
43,252 |
$7K |
| 93017 |
|
123 |
122 |
$7K |
| 32555 |
|
120 |
88 |
$7K |
| 99443 |
|
236 |
226 |
$7K |
| 85060 |
|
395 |
373 |
$7K |
| 87070 |
|
7,936 |
6,833 |
$7K |
| 85018 |
|
8,443 |
6,888 |
$7K |
| 00812 |
|
46 |
42 |
$7K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,342 |
1,063 |
$7K |
| 77077 |
|
47 |
47 |
$7K |
| 84134 |
|
1,080 |
1,051 |
$7K |
| 82550 |
|
36,812 |
26,240 |
$6K |
| 72072 |
|
298 |
294 |
$6K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
55 |
38 |
$6K |
| 74240 |
|
27 |
27 |
$6K |
| 82553 |
|
27,597 |
18,915 |
$6K |
| 73120 |
|
85 |
77 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
817 |
767 |
$6K |
| 97542 |
|
148 |
137 |
$6K |
| 0251 |
|
1,874 |
485 |
$6K |
| 81596 |
|
81 |
80 |
$6K |
| 88374 |
|
30 |
27 |
$6K |
| 92567 |
|
10,496 |
9,965 |
$6K |
| 92586 |
|
44 |
42 |
$6K |
| 72080 |
|
159 |
158 |
$6K |
| 29515 |
|
204 |
174 |
$6K |
| 82731 |
|
516 |
483 |
$6K |
| 76376 |
|
302 |
298 |
$6K |
| 95251 |
|
230 |
227 |
$6K |
| 60100 |
|
12 |
12 |
$5K |
| 82248 |
|
1,955 |
1,470 |
$5K |
| 87077 |
|
19,522 |
14,812 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,928 |
8,622 |
$5K |
| 86769 |
|
257 |
238 |
$5K |
| 87075 |
|
4,692 |
3,994 |
$5K |
| 87640 |
|
419 |
402 |
$5K |
| 69209 |
|
79 |
75 |
$5K |
| 29065 |
|
105 |
92 |
$5K |
| 90734 |
|
1,440 |
1,364 |
$5K |
| 12002 |
|
591 |
562 |
$5K |
| 12011 |
|
813 |
786 |
$5K |
| 72220 |
|
138 |
137 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,490 |
1,139 |
$5K |
| 99348 |
|
235 |
185 |
$5K |
| 99245 |
|
27 |
27 |
$5K |
| 93296 |
|
166 |
157 |
$5K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
891 |
510 |
$4K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
85 |
64 |
$4K |
| 80329 |
|
5,421 |
4,680 |
$4K |
| 86923 |
|
450 |
269 |
$4K |
| 90715 |
|
10,814 |
10,389 |
$4K |
| 90710 |
|
4,582 |
4,497 |
$4K |
| 93922 |
|
256 |
239 |
$4K |
| 83001 |
|
3,241 |
3,175 |
$4K |
| 30140 |
|
56 |
54 |
$4K |
| 87040 |
|
16,270 |
8,800 |
$4K |
| 83605 |
|
16,032 |
12,852 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
393 |
377 |
$4K |
| 52356 |
|
12 |
12 |
$4K |
| 77290 |
|
12 |
12 |
$4K |
| 90621 |
|
459 |
450 |
$4K |
| J3490 |
Unclassified drugs |
968 |
232 |
$4K |
| 92552 |
|
1,373 |
1,332 |
$4K |
| 72128 |
|
210 |
197 |
$4K |
| 87493 |
|
330 |
303 |
$4K |
| 51797 |
|
228 |
225 |
$4K |
| 87590 |
|
6,461 |
6,244 |
$4K |
| 97760 |
|
72 |
68 |
$3K |
| 82150 |
|
16,841 |
14,751 |
$3K |
| 94729 |
|
935 |
884 |
$3K |
| 90381 |
|
166 |
158 |
$3K |
| 97162 |
|
1,793 |
1,627 |
$3K |
| 84703 |
|
13,649 |
12,780 |
$3K |
| 31500 |
|
190 |
171 |
$3K |
| 76812 |
|
36 |
35 |
$3K |
| 86235 |
|
251 |
171 |
$3K |
| 88302 |
|
1,122 |
1,087 |
$3K |
| 92610 |
|
673 |
615 |
$3K |
| 99418 |
Prolong nursin fac eval 15m |
76 |
41 |
$3K |
| G0008 |
Administration of influenza virus vaccine |
2,645 |
2,417 |
$3K |
| 83550 |
|
9,027 |
8,563 |
$3K |
| 73650 |
|
41 |
38 |
$3K |
| 87631 |
|
389 |
362 |
$3K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,302 |
1,242 |
$3K |
| 99383 |
|
41 |
41 |
$3K |
| 88312 |
|
446 |
415 |
$3K |
| 86038 |
|
3,340 |
3,168 |
$3K |
| 87209 |
|
502 |
447 |
$3K |
| 82746 |
|
5,378 |
5,158 |
$3K |
| 72146 |
|
51 |
51 |
$3K |
| 84144 |
|
1,028 |
1,009 |
$3K |
| 88360 |
|
12 |
12 |
$3K |
| 11730 |
|
13 |
13 |
$3K |
| 86592 |
|
13,611 |
13,221 |
$3K |
| 87538 |
|
12 |
12 |
$3K |
| 85007 |
|
8,291 |
6,776 |
$3K |
| 0636 |
|
285 |
116 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
11,000 |
9,678 |
$3K |
| 94726 |
|
690 |
661 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
344,395 |
248,038 |
$2K |
| 86359 |
|
14 |
12 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
52,183 |
39,253 |
$2K |
| 96380 |
|
270 |
266 |
$2K |
| 82671 |
|
41 |
39 |
$2K |
| 99349 |
|
69 |
57 |
$2K |
| 29405 |
|
16 |
13 |
$2K |
| 75716 |
|
28 |
27 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
39,560 |
33,395 |
$2K |
| P9021 |
Red blood cells, each unit |
341 |
270 |
$2K |
| 90380 |
|
141 |
137 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
21,747 |
15,490 |
$2K |
| 82390 |
|
554 |
544 |
$2K |
| 99385 |
|
28 |
28 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
50,142 |
42,526 |
$2K |
| 29085 |
|
70 |
64 |
$2K |
| 84132 |
|
2,805 |
2,317 |
$2K |
| 84145 |
|
3,747 |
3,412 |
$2K |
| 80051 |
|
85 |
77 |
$2K |
| 99457 |
|
129 |
124 |
$2K |
| 96376 |
|
11,263 |
8,033 |
$2K |
| 01810 |
|
12 |
12 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
23,234 |
14,932 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
33,644 |
29,338 |
$2K |
| 29105 |
|
63 |
55 |
$2K |
| 86870 |
|
42 |
26 |
$2K |
| 82803 |
|
3,184 |
2,515 |
$2K |
| 99454 |
|
56 |
55 |
$2K |
| 77280 |
|
41 |
41 |
$2K |
| 81050 |
|
1,469 |
1,081 |
$2K |
| 92523 |
|
257 |
246 |
$2K |
| 88184 |
|
181 |
173 |
$2K |
| 36907 |
|
99 |
82 |
$2K |
| 86696 |
|
469 |
243 |
$1K |
| 93923 |
|
100 |
96 |
$1K |
| 99242 |
|
25 |
25 |
$1K |
| 87536 |
|
68 |
61 |
$1K |
| 99441 |
|
147 |
140 |
$1K |
| 86762 |
|
5,233 |
5,113 |
$1K |
| 72192 |
|
39 |
39 |
$1K |
| 84597 |
|
194 |
193 |
$1K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
1,046 |
426 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,913 |
2,370 |
$1K |
| 94660 |
|
243 |
183 |
$1K |
| 82570 |
|
6,082 |
5,567 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
6,781 |
5,199 |
$1K |
| 36620 |
|
50 |
38 |
$1K |
| 85613 |
|
45 |
31 |
$1K |
| 87581 |
|
1,564 |
1,509 |
$1K |
| 87486 |
|
1,564 |
1,509 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
9,659 |
4,449 |
$1K |
| 86140 |
|
19,080 |
17,465 |
$1K |
| 36416 |
|
83,373 |
53,886 |
$1K |
| 87147 |
|
4,674 |
2,577 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
463 |
437 |
$1K |
| 82805 |
|
1,302 |
1,097 |
$1K |
| 83883 |
|
29 |
13 |
$1K |
| 96127 |
|
156 |
155 |
$1K |
| 36600 |
|
1,189 |
1,048 |
$1K |
| 86901 |
|
18,203 |
16,487 |
$1K |
| 82140 |
|
2,762 |
2,145 |
$1K |
| 87899 |
|
2,483 |
1,201 |
$1K |
| 84100 |
|
11,871 |
9,866 |
$1K |
| 72114 |
|
12 |
12 |
$997.91 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
5,075 |
3,672 |
$994.48 |
| 99336 |
|
49 |
30 |
$990.86 |
| 88720 |
|
369 |
306 |
$940.03 |
| 94727 |
|
222 |
207 |
$933.47 |
| 82043 |
|
6,738 |
6,569 |
$925.79 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
8,305 |
7,479 |
$916.23 |
| 87338 |
|
146 |
142 |
$913.25 |
| 82103 |
|
545 |
524 |
$905.99 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15,318 |
14,860 |
$893.49 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
5,180 |
3,872 |
$880.45 |
| 95886 |
|
68 |
63 |
$868.88 |
| 82565 |
|
5,042 |
3,957 |
$865.87 |
| 82131 |
|
385 |
370 |
$852.87 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14,657 |
9,912 |
$834.98 |
| 95813 |
|
42 |
36 |
$828.22 |
| 99252 |
|
14 |
14 |
$816.64 |
| 71100 |
|
63 |
55 |
$810.04 |
| 77336 |
|
1,444 |
586 |
$806.25 |
| 99310 |
Prolong nursin fac eval 15m |
12 |
12 |
$804.65 |
| 76857 |
|
18 |
15 |
$797.40 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
7,337 |
3,625 |
$791.34 |
| 82784 |
|
2,565 |
2,150 |
$745.85 |
| 82575 |
|
34 |
32 |
$743.35 |
| 93297 |
|
48 |
48 |
$733.83 |
| 99001 |
|
596 |
486 |
$729.27 |
| 92081 |
|
12 |
12 |
$727.36 |
| 73020 |
|
14 |
12 |
$726.08 |
| 92133 |
|
125 |
122 |
$717.07 |
| 84432 |
|
14 |
12 |
$712.90 |
| 82010 |
|
2,406 |
2,029 |
$705.38 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
6,221 |
2,347 |
$693.17 |
| 82652 |
|
1,096 |
1,060 |
$670.82 |
| 16020 |
|
23 |
15 |
$640.19 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
9,274 |
5,336 |
$637.21 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
9,171 |
8,751 |
$633.47 |
| 84425 |
|
1,409 |
1,373 |
$619.38 |
| 86300 |
|
882 |
677 |
$596.31 |
| 96402 |
|
1,708 |
1,539 |
$576.44 |
| G0379 |
Direct admission of patient for hospital observation care |
76 |
71 |
$575.34 |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
877 |
474 |
$575.25 |
| 70487 |
|
12 |
12 |
$564.20 |
| 83993 |
|
25 |
24 |
$564.06 |
| 84460 |
|
2,990 |
2,469 |
$546.44 |
| 87632 |
|
87 |
78 |
$541.94 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
7,473 |
5,919 |
$539.52 |
| 87529 |
|
152 |
83 |
$534.79 |
| 80202 |
|
997 |
409 |
$531.49 |
| 83615 |
|
7,326 |
6,175 |
$529.68 |
| 85397 |
|
12 |
12 |
$513.26 |
| 84550 |
|
3,259 |
2,959 |
$511.67 |
| 93294 |
|
30 |
29 |
$508.33 |
| 83540 |
|
11,067 |
10,496 |
$503.06 |
| 99241 |
|
18 |
18 |
$499.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,747 |
8,557 |
$497.35 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,306 |
2,114 |
$492.81 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
2,890 |
1,733 |
$492.49 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
10,538 |
8,509 |
$483.41 |
| 82985 |
|
1,060 |
1,032 |
$475.76 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
7,655 |
3,795 |
$474.67 |
| 92551 |
|
106 |
104 |
$465.92 |
| 87045 |
|
1,384 |
1,295 |
$465.58 |
| 84207 |
|
1,178 |
1,144 |
$453.65 |
| 93226 |
|
19 |
14 |
$449.72 |
| 11981 |
|
385 |
374 |
$425.46 |
| 97166 |
|
512 |
461 |
$416.25 |
| 85045 |
|
1,590 |
1,503 |
$413.93 |
| 77332 |
|
24 |
24 |
$409.84 |
| 76937 |
|
143 |
126 |
$402.72 |
| J3480 |
Injection, potassium chloride, per 2 meq |
6,486 |
3,693 |
$392.39 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
7,656 |
6,872 |
$360.02 |
| 83002 |
|
2,643 |
2,595 |
$356.17 |
| C1729 |
Catheter, drainage |
3,727 |
1,953 |
$354.12 |
| J2704 |
Injection, propofol, 10 mg |
27,250 |
25,588 |
$353.63 |
| 86376 |
|
2,813 |
2,757 |
$349.90 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
37,065 |
28,126 |
$346.94 |
| J2060 |
Injection, lorazepam, 2 mg |
5,718 |
4,499 |
$341.40 |
| 99417 |
Prolong home eval add 15m |
25 |
25 |
$340.92 |
| 90633 |
|
6,043 |
5,835 |
$340.22 |
| 86200 |
|
1,708 |
1,650 |
$340.20 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
797 |
763 |
$339.79 |
| 87177 |
|
492 |
435 |
$339.75 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
4,837 |
2,841 |
$328.17 |
| 90673 |
|
32 |
32 |
$326.16 |
| 82107 |
|
37 |
36 |
$320.94 |
| J1644 |
Injection, heparin sodium, per 1000 units |
13,232 |
7,020 |
$311.78 |
| 82024 |
|
910 |
786 |
$302.44 |
| J1940 |
Injection, furosemide, up to 20 mg |
6,550 |
3,314 |
$298.24 |
| 86706 |
|
1,344 |
1,253 |
$293.89 |
| 74420 |
|
28 |
28 |
$293.01 |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
18 |
14 |
$290.83 |
| 87015 |
|
1,798 |
1,623 |
$290.42 |
| 86780 |
|
259 |
229 |
$288.85 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
3,777 |
2,357 |
$274.89 |
| 84450 |
|
2,991 |
2,470 |
$273.71 |
| 86635 |
|
212 |
168 |
$272.47 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
949 |
830 |
$268.85 |
| 96381 |
|
19 |
16 |
$267.82 |
| 77387 |
|
487 |
105 |
$264.35 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
21 |
20 |
$262.23 |
| 86141 |
|
1,236 |
1,185 |
$259.04 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,461 |
1,082 |
$250.40 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
5,487 |
4,866 |
$249.74 |
| 80164 |
|
90 |
68 |
$246.81 |
| 86364 |
|
221 |
217 |
$246.79 |
| 82627 |
|
1,697 |
1,664 |
$233.12 |
| 82105 |
|
1,564 |
1,506 |
$232.66 |
| 97165 |
|
2,591 |
2,337 |
$231.97 |
| 90662 |
|
1,908 |
1,790 |
$231.73 |
| 82947 |
|
5,655 |
5,375 |
$231.58 |
| 90686 |
|
11,783 |
11,504 |
$230.60 |
| 83014 |
|
608 |
602 |
$228.52 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
742 |
412 |
$227.90 |
| 82330 |
|
471 |
410 |
$207.93 |
| 86431 |
|
1,126 |
1,097 |
$193.35 |
| 93228 |
|
13 |
12 |
$192.16 |
| 85390 |
|
91 |
65 |
$186.46 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
5,579 |
4,419 |
$180.30 |
| J7050 |
Infusion, normal saline solution, 250 cc |
20,011 |
10,548 |
$179.06 |
| 0352U |
|
351 |
340 |
$178.30 |
| 85651 |
|
4,142 |
3,637 |
$172.91 |
| 85014 |
|
5,465 |
4,141 |
$172.56 |
| 36591 |
|
46 |
25 |
$171.12 |
| 83525 |
|
361 |
352 |
$170.55 |
| 82088 |
|
27 |
27 |
$167.10 |
| 82785 |
|
1,340 |
1,299 |
$166.63 |
| 86316 |
|
263 |
250 |
$166.62 |
| 84156 |
|
6,305 |
5,557 |
$164.46 |
| 88300 |
|
292 |
279 |
$155.59 |
| 84481 |
|
7,505 |
7,300 |
$150.05 |
| 92556 |
|
93 |
79 |
$148.21 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15,148 |
12,135 |
$146.47 |
| 86593 |
|
99 |
92 |
$142.80 |
| 51741 |
|
130 |
128 |
$140.08 |
| 86147 |
|
62 |
31 |
$139.79 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
1,851 |
1,378 |
$129.90 |
| 90649 |
|
35 |
30 |
$129.85 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
4,243 |
3,068 |
$123.88 |
| 86430 |
|
1,006 |
969 |
$118.71 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
18,314 |
16,416 |
$115.59 |
| 83498 |
|
298 |
294 |
$114.41 |
| J1953 |
Injection, levetiracetam, 10 mg |
1,510 |
1,113 |
$109.71 |
| 84681 |
|
382 |
372 |
$108.49 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
4,024 |
3,750 |
$103.55 |
| 90685 |
|
443 |
418 |
$101.96 |
| J1335 |
Injection, ertapenem sodium, 500 mg |
3,696 |
497 |
$100.58 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
50 |
48 |
$96.84 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,572 |
1,261 |
$92.10 |
| J3360 |
Injection, diazepam, up to 5 mg |
733 |
651 |
$92.02 |
| 99490 |
Ccm add 20min |
71 |
62 |
$88.90 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
970 |
890 |
$88.68 |
| 74300 |
|
384 |
362 |
$83.19 |
| 86146 |
|
51 |
25 |
$81.88 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
4,282 |
2,839 |
$72.81 |
| 99153 |
Mod sedat endo service >5yrs |
4,889 |
4,334 |
$70.75 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,758 |
1,660 |
$69.48 |
| 89051 |
|
826 |
600 |
$68.51 |
| J1956 |
Injection, levofloxacin, 250 mg |
3,830 |
1,912 |
$65.59 |
| 82104 |
|
495 |
481 |
$62.16 |
| 97535 |
Self-care/home management training, each 15 minutes |
1,590 |
1,281 |
$61.95 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
5,834 |
4,356 |
$59.40 |
| 87102 |
|
82 |
67 |
$59.38 |
| 82525 |
|
273 |
270 |
$56.31 |
| Q3014 |
Telehealth originating site facility fee |
162 |
153 |
$55.85 |
| 80197 |
|
108 |
77 |
$55.46 |
| 87076 |
|
90 |
63 |
$55.15 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
2,378 |
1,984 |
$54.52 |
| 90680 |
|
7,992 |
7,876 |
$51.15 |
| 84436 |
|
1,283 |
1,212 |
$50.00 |
| 85049 |
|
1,723 |
1,661 |
$49.24 |
| 86694 |
|
407 |
201 |
$47.50 |
| 86812 |
|
40 |
40 |
$46.68 |
| J0456 |
Injection, azithromycin, 500 mg |
807 |
465 |
$46.34 |
| 82977 |
|
139 |
133 |
$45.68 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
84 |
83 |
$45.36 |
| 94002 |
|
65 |
58 |
$44.80 |
| 84630 |
|
288 |
285 |
$43.78 |
| 84255 |
|
132 |
131 |
$40.73 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
2,740 |
1,567 |
$39.72 |
| 85384 |
|
193 |
173 |
$39.64 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,630 |
2,157 |
$38.11 |
| 99406 |
|
866 |
814 |
$35.75 |
| 80177 |
|
13 |
13 |
$35.08 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
1,328 |
617 |
$33.96 |
| 86695 |
|
469 |
243 |
$33.62 |
| G0009 |
Administration of pneumococcal vaccine |
1,101 |
1,028 |
$32.90 |
| 87210 |
|
363 |
354 |
$32.56 |
| 95012 |
|
500 |
488 |
$31.75 |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
398 |
240 |
$28.89 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
143 |
101 |
$28.09 |
| 84165 |
|
852 |
765 |
$27.26 |
| 83037 |
|
188 |
185 |
$26.56 |
| 84244 |
|
27 |
26 |
$25.36 |
| A4353 |
Intermittent urinary catheter, with insertion supplies |
1,256 |
1,095 |
$25.26 |
| 90656 |
|
1,147 |
1,133 |
$24.67 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
272 |
266 |
$23.73 |
| 90688 |
|
189 |
172 |
$22.08 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
469 |
410 |
$21.82 |
| 90697 |
|
3,154 |
3,126 |
$18.38 |
| 83935 |
|
42 |
38 |
$18.11 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
143 |
131 |
$15.80 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
159 |
148 |
$15.68 |
| 87420 |
|
203 |
200 |
$15.49 |
| 86704 |
|
238 |
232 |
$14.69 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
110 |
104 |
$14.17 |
| J1790 |
Injection, droperidol, up to 5 mg |
910 |
829 |
$14.10 |
| 86225 |
|
152 |
150 |
$13.94 |
| 93325 |
|
17 |
13 |
$13.08 |
| 84466 |
|
435 |
422 |
$13.06 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
1,672 |
1,570 |
$11.08 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
266 |
233 |
$10.32 |
| 94760 |
|
13 |
13 |
$10.17 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
375 |
279 |
$9.29 |
| 86308 |
|
83 |
83 |
$8.98 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
179 |
177 |
$8.78 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,472 |
4,156 |
$8.53 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
1,580 |
1,459 |
$8.04 |
| 99173 |
|
107 |
105 |
$6.83 |
| J7612 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
404 |
306 |
$6.30 |
| 82310 |
|
46 |
44 |
$5.24 |
| J3535 |
Drug administered through a metered dose inhaler |
338 |
312 |
$5.01 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,984 |
2,439 |
$4.61 |
| 84300 |
|
58 |
51 |
$4.32 |
| J3411 |
Injection, thiamine hcl, 100 mg |
602 |
401 |
$4.17 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
1,113 |
982 |
$3.00 |
| 84155 |
|
967 |
862 |
$2.96 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
116 |
71 |
$2.80 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,340 |
2,354 |
$2.64 |
| 84157 |
|
109 |
91 |
$2.24 |
| S0028 |
Injection, famotidine, 20 mg |
2,876 |
1,861 |
$1.77 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
6,446 |
5,304 |
$1.17 |
| 90700 |
|
1,961 |
1,900 |
$1.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
1,022 |
813 |
$0.85 |
| J7510 |
Prednisolone oral, per 5 mg |
959 |
866 |
$0.48 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,484 |
1,167 |
$0.44 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
684 |
567 |
$0.16 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
1,022 |
808 |
$0.16 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
559 |
411 |
$0.07 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
307 |
153 |
$0.05 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,324 |
1,135 |
$0.04 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
132 |
112 |
$0.01 |
| 3074F |
|
69,315 |
64,917 |
$0.00 |
| 90647 |
|
762 |
685 |
$0.00 |
| 3075F |
|
5,976 |
5,678 |
$0.00 |
| 3079F |
|
16,294 |
15,453 |
$0.00 |
| 3044F |
|
2,415 |
2,148 |
$0.00 |
| 1126F |
|
93,599 |
86,339 |
$0.00 |
| 90696 |
|
1,924 |
1,893 |
$0.00 |
| 86160 |
|
717 |
358 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
171 |
168 |
$0.00 |
| 82952 |
|
821 |
805 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
1,374 |
1,309 |
$0.00 |
| 90698 |
|
4,839 |
4,795 |
$0.00 |
| 90723 |
|
2,018 |
1,931 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
936 |
797 |
$0.00 |
| 90744 |
|
1,878 |
1,862 |
$0.00 |
| 84402 |
|
2,701 |
2,643 |
$0.00 |
| 84446 |
|
227 |
226 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
372 |
354 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,046 |
1,837 |
$0.00 |
| 84154 |
|
1,155 |
1,131 |
$0.00 |
| 86301 |
|
25 |
25 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
442 |
337 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
97 |
92 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
233 |
124 |
$0.00 |
| C1750 |
Catheter, hemodialysis/peritoneal, long-term |
16 |
12 |
$0.00 |
| 3080F |
|
201 |
194 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
316 |
286 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
86 |
83 |
$0.00 |
| C1781 |
Mesh (implantable) |
531 |
518 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
631 |
600 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
297 |
286 |
$0.00 |
| 82945 |
|
63 |
52 |
$0.00 |
| 90716 |
|
58 |
48 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
1,235 |
1,134 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
440 |
336 |
$0.00 |
| 76872 |
|
14 |
12 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
157 |
131 |
$0.00 |
| 86381 |
|
340 |
333 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
346 |
204 |
$0.00 |
| A4338 |
Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each |
32 |
27 |
$0.00 |
| C2627 |
Catheter, suprapubic/cystoscopic |
190 |
132 |
$0.00 |
| 90622 |
|
44 |
42 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
24 |
12 |
$0.00 |
| 83921 |
|
89 |
82 |
$0.00 |
| 45381 |
|
41 |
41 |
$0.00 |
| A9561 |
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries |
26 |
25 |
$0.00 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
66 |
53 |
$0.00 |
| 90674 |
|
70 |
66 |
$0.00 |
| 93797 |
|
13 |
13 |
$0.00 |
| C1884 |
Embolization protective system |
21 |
19 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
26 |
24 |
$0.00 |
| 64615 |
|
12 |
12 |
$0.00 |
| 94644 |
|
13 |
13 |
$0.00 |
| J0611 |
Injection, calcium gluconate (wg critical care), per 10 ml |
25 |
14 |
$0.00 |
| 99407 |
|
13 |
13 |
$0.00 |
| J2358 |
Injection, olanzapine, long-acting, 1 mg |
26 |
25 |
$0.00 |
| J3030 |
Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
15 |
14 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
43 |
28 |
$0.00 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
19 |
13 |
$0.00 |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
21 |
12 |
$0.00 |
| 0500F |
|
14 |
14 |
$0.00 |
| 3078F |
|
76,042 |
70,561 |
$0.00 |
| 1159F |
|
10,937 |
9,618 |
$0.00 |
| 90648 |
|
2,858 |
2,799 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
989 |
954 |
$0.00 |
| 3077F |
|
7,459 |
6,943 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
233 |
183 |
$0.00 |
| 86708 |
|
138 |
136 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
4,555 |
2,765 |
$0.00 |
| C1758 |
Catheter, ureteral |
2,372 |
2,114 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
55 |
54 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
62 |
61 |
$0.00 |
| 0502F |
|
2,430 |
1,793 |
$0.00 |
| J0701 |
Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg |
98 |
42 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
26 |
25 |
$0.00 |
| A4565 |
Slings |
1,119 |
1,025 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,941 |
1,482 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
64 |
55 |
$0.00 |
| 3051F |
|
81 |
79 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
72 |
63 |
$0.00 |
| 85347 |
|
330 |
192 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
397 |
302 |
$0.00 |
| 86162 |
|
26 |
25 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
256 |
217 |
$0.00 |
| 87641 |
|
433 |
416 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
232 |
184 |
$0.00 |
| 83630 |
|
58 |
52 |
$0.00 |
| 92611 |
|
162 |
158 |
$0.00 |
| 90682 |
|
82 |
75 |
$0.00 |
| 86360 |
|
14 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
537 |
528 |
$0.00 |
| 90681 |
|
140 |
140 |
$0.00 |
| 82180 |
|
180 |
178 |
$0.00 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
100 |
72 |
$0.00 |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
478 |
225 |
$0.00 |
| 90746 |
|
157 |
156 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
361 |
358 |
$0.00 |
| 84112 |
|
70 |
62 |
$0.00 |
| 84590 |
|
264 |
261 |
$0.00 |
| J2185 |
Injection, meropenem, 100 mg |
56 |
26 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
129 |
124 |
$0.00 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
28 |
25 |
$0.00 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
125 |
108 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
45 |
24 |
$0.00 |
| 88325 |
|
43 |
33 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
12 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
17 |
16 |
$0.00 |
| 51784 |
|
50 |
49 |
$0.00 |
| 77002 |
|
30 |
30 |
$0.00 |
| 70546 |
|
13 |
13 |
$0.00 |
| 90707 |
|
97 |
82 |
$0.00 |
| 90653 |
|
73 |
55 |
$0.00 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
35 |
30 |
$0.00 |
| 93356 |
|
65 |
64 |
$0.00 |
| 81002 |
|
40 |
38 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
40 |
28 |
$0.00 |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
39 |
25 |
$0.00 |
| 82232 |
|
25 |
25 |
$0.00 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
20 |
18 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
38 |
12 |
$0.00 |
| 85306 |
|
14 |
13 |
$0.00 |
| 87535 |
|
12 |
12 |
$0.00 |